Recall Radar
All recallsMedicine & devices

Erythromycin Tablets, USP, 250 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pe…

CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit

Class II Medicine & devices FDA May 27, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
Zydus Pharmaceuticals (USA) Inc — Pennington, NJ
Severity
Class II — moderate
Reported
May 27, 2026
Quantity
23,880 bottles
Recall number
D-0544-2026
Status
Ongoing
Source
FDA

Where it went

Nationwide within the U.S

Other medicine & devices recalls

See every current recall on the live dashboard →